CD8A and neoplasm: Therapeutically targeting NSUN2 can directly interfere with these critical molecular pathways, inhibiting tumor growth and metastasis while reducing the expression of immunosuppressive factors, enhancing CD8+ T cell activation and infiltration, and providing a potential strategy for combination with immunotherapy (29).